Podcast Episodes
Back to Search
Musk and Altman's Legal Proceedings: Day 3
In this episode, we discuss important events from the ongoing Musk versus Altman trial. The episode also addresses the transparency issues faced by S…
2 weeks ago
Uncovering Conflict: Altman and CFO
In this episode, we uncover the conflict between Sam Altman and OpenAI's CFO. Additionally, we discuss the EU's suspension of the AI Act and the cont…
2 weeks, 1 day ago
OpenAI's Separation from Microsoft: A New Era
In this episode, we look at OpenAI's separation from Microsoft as a start of a new era. We'll also cover the groundbreaking $1.1 billion funding rais…
2 weeks, 2 days ago
ChatGPT 5.5: Unpacking Key Changes
In this episode, we unpack the key changes introduced with ChatGPT 5.5. SpaceX's GPU developments also get our attention. See Privacy Policy at https…
2 weeks, 5 days ago
Forget What You Know: Google’s AI Strategy
In this episode, we encourage you to forget previous notions of AI as we discuss Google’s multi-layer strategy from Cloud Next. Discover an innovativ…
3 weeks ago
New Apple CEO, OpenAI's New Image Model, Vercel AI Hack
In this episode, we explore the significant leadership change at Apple as Tim Cook steps down and John Tarnas takes the helm, amid ongoing challenges…
3 weeks, 1 day ago
Anthropic Financially Surpasses OpenAI
In this episode, we highlight Anthropic's financial success as it overtakes OpenAI. Explore the implications for future AI advancements. See Privacy …
3 weeks, 2 days ago
Understanding the Upgrade Path for Codex
In this episode, we discuss the upgrade path for Codex and its implications for developers. Discover what these changes mean for the future. See Priv…
3 weeks, 5 days ago
Opus 4.7 Launch: Anthropic's Strategic Growth
In this episode, we examine how Anthropic's launch of Opus 4.7 fits into their strategic growth with a $2 billion backing. We also discuss their deal…
3 weeks, 6 days ago
Non-Traditional Views on Anthropic's IPO
In this episode, we share non-traditional views on Anthropic's move toward an IPO. We also discuss the significant collaboration between Novo Nordisk…
4 weeks ago